StockNews.com began coverage on shares of GlycoMimetics (NASDAQ:GLYC – Get Rating) in a research note issued to investors on Thursday. The firm issued a sell rating on the biotechnology company’s stock. Separately, HC Wainwright reissued a buy rating and issued a $8.00 target price on shares of GlycoMimetics in a report on Thursday, March 30th. […]
StockNews.com began coverage on shares of GlycoMimetics (NASDAQ:GLYC – Get Rating) in a research report sent to investors on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and issued a $8.00 target price on shares of GlycoMimetics in a research note on Thursday, March […]
GlycoMimetics, Inc. (NASDAQ:GLYC – Get Rating) saw a large decline in short interest during the month of April. As of April 30th, there was short interest totalling 1,350,000 shares, a decline of 13.5% from the April 15th total of 1,560,000 shares. Based on an average daily volume of 1,080,000 shares, the short-interest ratio is presently […]
GlycoMimetics, Inc. (NASDAQ:GLYC – Get Rating) – Analysts at HC Wainwright lowered their Q2 2023 earnings per share (EPS) estimates for GlycoMimetics in a note issued to investors on Thursday, May 4th. HC Wainwright analyst E. White now expects that the biotechnology company will earn ($0.16) per share for the quarter, down from their previous […]
GlycoMimetics, Inc. (NASDAQ:GLYC – Get Rating) shares passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $1.89 and traded as low as $1.32. GlycoMimetics shares last traded at $1.46, with a volume of 144,418 shares. Analysts Set New Price Targets Several […]